Ann: Appendix 4D & 1H FY25 Report, page-163

  1. bar
    1,019 Posts.
    lightbulb Created with Sketch. 177
    i am excited about the alluded to product the particulate product to come on board in 2026. It will be used as a polyfiller type remedy in surgical situations where they need to fill a gap. Also in the little mentioned orthopaedic field it might be used in crumbly osteoporotic patients to help fracture healing. Even in the fit athlete who has a crucial or tendo Achilles problem it could help heal the problem and give a stronger result and outcome. Tendons do not have a great blood supply so this product could help. DW has talked about rotator cuff and surgeons asking for product. If its available as an injection in a syringe it could be injected for partial tears and might be used in hamstring injuries as an injection under ultrasound control, a very common practice. The above areas do not involve the biological presently . We could have the field to ourselves. And we have yet to cover the cosmetic field. I do not think Swami should cover this. He is too noble. Sorry but it’s over to DW.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.21
Change
0.020(1.69%)
Mkt cap ! $832.4M
Open High Low Value Volume
$1.18 $1.23 $1.17 $2.070M 1.719M

Buyers (Bids)

No. Vol. Price($)
2 24841 $1.21
 

Sellers (Offers)

Price($) Vol. No.
$1.22 21540 3
View Market Depth
Last trade - 16.18pm 24/06/2025 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.